OBJECTIVE: To determine whether estrogen down-regulates MCP-1 in vascular endothelial cells. DESIGN: A prospective comparative study. SETTING: Academic research environment. PATIENT(S): Human umbilical vein endothelial cells (n = 3) and human coronary artery endothelial cells (n = 3) obtained from females. INTERVENTION(S): Human umbilical vein endothelial cells (HUVEC) and human coronary artery endothelial cells (HCAEC) were grown to preconfluence. Then, they were treated with various concentrations of estradiol (10(-11) M to 10(-7) M) as well as raloxifene (10(-7) M) and tamoxifen (10(-7) M). MCP-1 in culture media was quantified using an enzyme-linked immunosorbent assay (ELISA). Cellular ribonucleic acid (RNA) was extracted and Northern blots were hybridized with an oligonucleotide probe complementary to a specific sequence of MCP-1 mRNA. MAIN OUTCOME MEASURE(S): MCP-1 protein and mRNA. RESULT(S): Estrogen treatment did not change MCP-1 expression in HUVEC. On the other hand, in HCAEC, estradiol induced a 30% decrease in mRNA expression and resulted in dose-dependent inhibition of MCP-1 production as detected by ELISA. Raloxifene and tamoxifen also resulted in inhibition of MCP-1 mRNA and protein expression. CONCLUSION(S): Our findings suggest that one of the mechanisms by which estrogen down-regulates atherosclerosis is by suppressing vascular MCP-1 expression, resulting in decreased macrophage recruitment.
OBJECTIVE: To determine whether estrogen down-regulates MCP-1 in vascular endothelial cells. DESIGN: A prospective comparative study. SETTING: Academic research environment. PATIENT(S): Human umbilical vein endothelial cells (n = 3) and human coronary artery endothelial cells (n = 3) obtained from females. INTERVENTION(S): Human umbilical vein endothelial cells (HUVEC) and human coronary artery endothelial cells (HCAEC) were grown to preconfluence. Then, they were treated with various concentrations of estradiol (10(-11) M to 10(-7) M) as well as raloxifene (10(-7) M) and tamoxifen (10(-7) M). MCP-1 in culture media was quantified using an enzyme-linked immunosorbent assay (ELISA). Cellular ribonucleic acid (RNA) was extracted and Northern blots were hybridized with an oligonucleotide probe complementary to a specific sequence of MCP-1 mRNA. MAIN OUTCOME MEASURE(S): MCP-1 protein and mRNA. RESULT(S): Estrogen treatment did not change MCP-1 expression in HUVEC. On the other hand, in HCAEC, estradiol induced a 30% decrease in mRNA expression and resulted in dose-dependent inhibition of MCP-1 production as detected by ELISA. Raloxifene and tamoxifen also resulted in inhibition of MCP-1 mRNA and protein expression. CONCLUSION(S): Our findings suggest that one of the mechanisms by which estrogen down-regulates atherosclerosis is by suppressing vascular MCP-1 expression, resulting in decreased macrophage recruitment.
Authors: Judit Kiss; József Tímár; Beáta Somlai; Katalin Gilde; Zsuzsanna Fejôs; István Gaudi; Andrea Ladányi Journal: Pathol Oncol Res Date: 2007-03-27 Impact factor: 3.201
Authors: William F Johnston; Morgan Salmon; Gang Su; Guanyi Lu; Gorav Ailawadi; Gilbert R Upchurch Journal: J Vasc Surg Date: 2014-02-28 Impact factor: 4.268
Authors: Brian G Choi; Gemma Vilahur; M Urooj Zafar; Luis Cardoso; Daniel Yadegar; Borja Ibanez; James Tunstead; Juan F Viles-Gonzalez; Mitchell B Schaffler; Valentin Fuster; Juan J Badimon Journal: Atherosclerosis Date: 2008-02-21 Impact factor: 5.162
Authors: Andrea Miró-Canturri; Rafael Ayerbe-Algaba; Raquel Del Toro; Manuel Enrique-Jiménez Mejías; Jerónimo Pachón; Younes Smani Journal: Pharmaceuticals (Basel) Date: 2021-05-26
Authors: Aida Sivro; Julie Lajoie; Joshua Kimani; Walter Jaoko; Francis A Plummer; Keith Fowke; T Blake Ball Journal: Immun Ageing Date: 2013-10-22 Impact factor: 6.400